Natural Alternatives International Inc: Form 10-Q for the period ended Dec 31, 2021
Filed with the SEC on Feb 9, 2022 and accepted by EDGAR at Feb 9, 2022, 16:15 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2021-10-01 to 2021-12-31 | $37.7m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Revenue | 6 months2021-07-01 to 2021-12-31 | $76.1m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Cost of revenue | 3 months2021-10-01 to 2021-12-31 | $31.2m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2021-07-01 to 2021-12-31 | $61.2m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2021-10-01 to 2021-12-31 | $6.5m | us-gaap:GrossProfit |
| Gross profit | 6 months2021-07-01 to 2021-12-31 | $14.8m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2021-10-01 to 2021-12-31 | $4.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2021-07-01 to 2021-12-31 | $8.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2021-10-01 to 2021-12-31 | $2.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2021-07-01 to 2021-12-31 | $6.6m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2021-10-01 to 2021-12-31 | $545.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2021-07-01 to 2021-12-31 | $1.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2021-10-01 to 2021-12-31 | $1.8m | us-gaap:NetIncomeLoss |
| Net income | 6 months2021-07-01 to 2021-12-31 | $5.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2021-10-01 to 2021-12-31 | $0.30 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2021-07-01 to 2021-12-31 | $0.81 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2021-10-01 to 2021-12-31 | $0.30 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2021-07-01 to 2021-12-31 | $0.82 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2021-10-01 to 2021-12-31 | 6,256,498 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2021-07-01 to 2021-12-31 | 6,303,921 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2021-07-01 to 2021-12-31 | −$557.0k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2021-07-01 to 2021-12-31 | $19.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 6 months2021-07-01 to 2021-12-31 | $2.5m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2021-12-31 | $19.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2021-12-31 | $70.6m | us-gaap:AssetsCurrent |
| Total assets | At period end2021-12-31 | $127.4m | us-gaap:Assets |
| Current liabilities | At period end2021-12-31 | $16.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2021-12-31 | $43.0m | us-gaap:Liabilities |
| Shareholders' equity | At period end2021-12-31 | $84.4m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001437749-22-002872. Last ingested by Listed: Oct 24, 2026, 14:56 ET. Listed shows no prices and gives no investment advice.